Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease

Archives of Neurology

Volumn 63, Issue 6, 2006, Pages 876-880

  Krasnianski, Anna ^a   Meissner, Bettina ^a   Schulz Schaeffer, Walter ^a   Kallenberg, Kai ^a   Bartl, Mario ^a   Heinemann, Uta ^a   Varges, Daniela ^a   Kretzschmar, Hans A ^b   Zerr, Inga ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; APHASIA; APRAXIA; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; ELECTROENCEPHALOGRAM; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

14-3-3 PROTEINS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBRAL CORTEX; COGNITION DISORDERS; CREUTZFELDT-JAKOB SYNDROME; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; NEUROPSYCHOLOGICAL TESTS; S100 PROTEINS;

EID: 33745086983     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.6.876     Document Type: Article

References (16)

1. Zerr I, Poser S. Clinical diagnosis and differential diagnosis of CJD and vCJD with special emphasis on laboratory tests. APMIS. 2002;110:88-98.
2. Parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 1996;39:767-778.
3. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46:224-233.
4. Castellani RJ, Colucci M, Xie Z, et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology. 2004;63:436-442.
5. Hamaguchi T, Kitamoto T, Sato T, et al. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology. 2005;64:643-648.
6. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000;55:811-815.
7. Human transmissible spongiform encephalopathies. Wkly Epidemiol Rec. 1998;73:361-365.
8. Steinhoff BJ, Räcker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol. 1996;53:162-166.
9. Kitamoto T, Shin RW, Doh-Ura K, et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol. 1992;140:1285-1294.
10. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 1996;53:913-920.
11. Schulz-Schaeffer WJ, Tschoke S, Kranefuss N, et al. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol. 2000;156:51-56.
12. Windl O, Giese A, Schulz-Schaeffer W, et al. Molecular genetics of human prion diseases in Germany. Hum Genet. 1999;105:244-252.
13. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998;43:32-40.
14. O'Brien HL, Tetewsky SJ, Avery LM, Cushman CA, Makous W, Duffy CJ. Visual mechanisms of spatial disorientation in Alzheimer's disease. Cereb Cortex. 2001;11:1083-1102.
15. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004;63:443-449.
16. Zerr I, Schulz-Schaeffer WJ, Giese A, et al. Current clinical diagnosis in CJD: identification of uncommon variants. Ann Neurol. 2000;48:323-329.